Horizon has been ranked as one of the fastest growing biotechnology companies in Europe by Deloitte with a staff of more than 120 people (200) spread across scientific, operations and commercial functions and accommodated within a >40,000 sq. ft. sq. ft. (>80,000) state-of-art facilities in Cambridge, MA, USA. The company has grown rapidly and now has a customer base approaching 1,000 organisations including major pharmaceutical, biotech and diagnostic companies as well as leading academic research centres. Horizon was named the 2014 European Mediscience Emerging Star Award following its £68.6 million IPO on the AIM market of the LSE and an all-time record for a Life Science company.
Horizon was founded by Dr Chris Torrance and Professor Alberto Bardelli and builds upon a 20 year heritage in oncology research, translational medicine and genome-editing.